|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-6-6
|
|
pubmed:abstractText |
Preoperative chemoradiotherapy has demonstrated to improve resectability and local control in locally advanced rectal cancer (LARC). 5-fluorouracil (5FU) has traditionally been the drug of choice in combination with radiation therapy. Early studies of capecitabine (CAP) have shown its potential to replace 5FU. Between March 2002 and April 2005, 31 patients with newly diagnosed LARC (T2 N+ 2 cases, T3 N0-N+ 25 cases, T4 N0-N+ 4 cases) received the combined treatment. Surgery was planned 6-8 weeks after chemoradiation. Adjuvant chemotherapy with 5FU plus leucovorin for 6 courses was given in pN+ patients. All patients completed the planned treatment. Grade 3 acute toxicity was observed in 5 patients (16%). Nineteen patients (61%) had a downstaging. A complete pathological remission was observed in 3 cases (10%). Median follow-up is of 23 months (range; 6-36 months). The results of this experience confirm the data of the literature about the feasibility and efficacy of a neoadjuvant treatment with radiation and CAP in LARC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0392-9078
|
|
pubmed:author |
pubmed-author:AmichettiMM,
pubmed-author:CaraulBB,
pubmed-author:CasulaGG,
pubmed-author:DeiddaM AMA,
pubmed-author:DessìMM,
pubmed-author:FarciDD,
pubmed-author:FariguRR,
pubmed-author:HSUT PTP,
pubmed-author:MaxiaLL,
pubmed-author:MurtasRR,
pubmed-author:OrrùSS
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
61-70
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17550133-Adenocarcinoma,
pubmed-meshheading:17550133-Adult,
pubmed-meshheading:17550133-Aged,
pubmed-meshheading:17550133-Antimetabolites, Antineoplastic,
pubmed-meshheading:17550133-Chemotherapy, Adjuvant,
pubmed-meshheading:17550133-Combined Modality Therapy,
pubmed-meshheading:17550133-Deoxycytidine,
pubmed-meshheading:17550133-Digestive System Surgical Procedures,
pubmed-meshheading:17550133-Feasibility Studies,
pubmed-meshheading:17550133-Female,
pubmed-meshheading:17550133-Fluorouracil,
pubmed-meshheading:17550133-Humans,
pubmed-meshheading:17550133-Kaplan-Meier Estimate,
pubmed-meshheading:17550133-Leucovorin,
pubmed-meshheading:17550133-Lymph Node Excision,
pubmed-meshheading:17550133-Male,
pubmed-meshheading:17550133-Middle Aged,
pubmed-meshheading:17550133-Neoadjuvant Therapy,
pubmed-meshheading:17550133-Neoplasm Invasiveness,
pubmed-meshheading:17550133-Radiotherapy, Adjuvant,
pubmed-meshheading:17550133-Rectal Neoplasms,
pubmed-meshheading:17550133-Treatment Outcome,
pubmed-meshheading:17550133-Vitamin B Complex
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Phase II study of preoperative irradiation and chemotherapy with capecitabine in patients with locally advanced rectal carcinoma.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Cagliari University, Cagliari, Italy.
|
|
pubmed:publicationType |
Journal Article
|
